Valuable hematological indicators for the diagnosis and severity assessment of Chinese children with community-acquired pneumonia Prealbumin

Medicine (United States)

Volumn 95, Issue 47, 2016, Pages

  Ning, Jingjing ^a   Shao, Xiaonan ^a   Ma, Yibo ^b   Lv, Darong ^c  

^a Department of Pediatrics ^*  (China)

^b THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c THE AFFILIATED CHANGZHOU NO 2 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Children; Community acquired pneumonia; Diagnosis; Prealbumin; Severity assessment

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN M ANTIBODY; PREALBUMIN; PROCALCITONIN; BIOLOGICAL MARKER;

ARTICLE; CHILD; CHINESE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY ASSESSMENT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIA; NEUTROPHIL COUNT; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SEASONAL VARIATION; SENSITIVITY AND SPECIFICITY; VITAL SIGN; ADOLESCENT; BLOOD; CASE CONTROL STUDY; CHINA; COMMUNITY-ACQUIRED INFECTIONS; INFANT; METABOLISM; MICROBIOLOGY; PNEUMONIA; PNEUMONIA, MYCOPLASMA; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; BIOMARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHINA; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; INFANT; MALE; PNEUMONIA; PNEUMONIA, MYCOPLASMA; PREALBUMIN; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VITAL SIGNS;

EID: 85006057031     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000005452     Document Type: Article

References (28)

1. Clark JE, Hammal D, Hampton F, et al. Epidemiology of communityacquired pneumonia in children seen in hospital. Epidemiol Infect 2007;135:262-9.
2. Cardinale F, Cappiello AR, Mastrototaro MF, et al. Communityacquired pneumonia in children. Early Hum Dev 2013;89:S49-52.
3. Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax 2011;66(suppl 2):ii1-23.
4. Myron Johnson A, Merlini G, Sheldon J, et al. Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition. Clin Chem Lab Med 2007;45:419-26.
5. Gao HL, Zhang CG, Zhu LL, et al. Clinical significance of determinations of serum procalcitonin, prealbumin and C-reactive protein in children with infection diseases. J Appl Clin Pediatr 2009;24:889-904.
6. Subspecialty Group of Respiratory Diseases T, Society of Pediatrics CM AGuidelines for management of community acquired pneumonia in children (the revised edition of 2013) (I). Zhonghua er ke za zhi 2013;51:745-52.
7. Subspecialty Group of Respiratory Diseases T, Society of Pediatrics CM AGuidelines for management of community acquired pneumonia in children (the revised edition of 2013) (II). Zhonghua er ke za zhi 2013; 51:856-62.
8. Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004;113:701-7.
9. Defilippi A, Silvestri M, Tacchella A, et al. Epidemiology and clinical features of Mycoplasma pneumoniae infection in children. Respir Med 2008;102:1762-8.
10. Waites KB. New concepts of Mycoplasma pneumoniae infections in children. Pediatr Pulmonol 2003;36:267-78.
11. Shu LH, Xu JJ, Wang S, et al. Distribution of pathogenic microorganisms and its relationship with clinical features in children with communityacquired pneumonia. Chin J Contemp Pediatr 2015;17:1056-61.
12. Yin Y, Lu Q, Yan X. Epidemiology of Mycoplasma pneumoniae infections. Zhonghua Er Ke Za Zhi 2016;54:91-3.
13. Howie SR, Morris GA, Tokarz R, et al. Etiology of severe childhood pneumonia in the Gambia, West Africa, determined by conventional and molecular microbiological analyses of lung and pleural aspirate samples. Clin Infect Dis 2014;59:682-5.
14. Snider RH, Nylen ES, Becker KL. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J Investig Med 1997;45:552-60.
15. Muller B, White JC, Nylen ES, et al. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001;86:396-404.
16. Sierra R, Rello J, Bailén MA, et al. C-reactive protein used as an early indicator of infection in patients with systemic inflammatory response syndrome. Intensive Care Med 2004;30:2038-45.
17. Yo CH, Hsieh PS, Lee SH, et al. Comparison of the test characteristics of procalcitonin to C-reactive protein and leukocytosis for the detection of serious bacterial infections in children presenting with fever without source: a systematic review and meta-analysis. Ann Emerg Med 2012; 60:591-600.
18. Pereira JM, Teixeira-Pinto A, Basilio C, et al. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia? J Crit Care 2013;28:970-4.
19. Zheng XL, Xue LH. The changes in hs-CRP and PCT levels and cellular immunity indicators in peripheral blood and their clinic significance in children pneumonia. J Clin Pediatr 2013;31:22-5.
20. Gilbert DN. Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis 2011;52(suppl 4):S346-50.
21. Lee H. Procalcitonin as a biomarker of infectious diseases. Korean J Intern Med 2013;28:285-91.
22. Rey C, Los Arcos M, Concha A, et al. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children. Intensive Care Med 2007;33: 477-84.
23. Hrnciarikova D, Juraskova B, Hyspler R, et al. A changed view of serum prealbumin in the elderly: prealbumin values influenced by concomitant inflammation. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2007;151:273-6.
24. Shao ZL, Sun BL, Zhao JM. Clinical value of serum adenosine deaminase and prealbumin in identification of pathogens isolated from children with pneumonia. Chin J Nosocomiol 2016;26:2361-3.
25. Smyth A, Carty H, Hart CA. Clinical predictors of hypoxaemia in children with pneumonia. Ann Trop Paediatr 1998;18:31-40.
26. Lee JY, Hwang SJ, Shim JW, et al. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia. Korean J Lab Med 2010;30:406-13.
27. Agnello L, Bellia C, Di GangiM, et al. Utility of serum procalcitonin and C-reactive protein in severity assessment of community-acquired pneumonia in children. Clin Biochem 2016;49:47-50.
28. Liao WJ, Li YM, Chen T, et al. Determination of serum acute phase reaction protein in patients with severe acute respiratory syndrome. Chin J Preventive Mes 2004;38:92-3.